Evaluation of gut microbiota composition in elite controllers and antiretroviral-treated people with HIV after aspirin versus atorvastatin administration
β
Just Accepted
https://bit.ly/4jOsf4a

@jidjournal.bsky.social
In publication since 1904, JID is the premier global journal for original research on infectious diseases. JID is an official journal of @idsainfo.bsky.social
Evaluation of gut microbiota composition in elite controllers and antiretroviral-treated people with HIV after aspirin versus atorvastatin administration
β
Just Accepted
https://bit.ly/4jOsf4a
Translational and phase I evaluation of AZD0292, a novel, half-life extended anti-Pseudomonal Psl-PcrV bispecific monoclonal antibody
β
Just Accepted
π https://bit.ly/4ekWUm3
Chlamydia trachomatis (CT) antibody-mediated opsonophagocytosis is not associated with reduced endometrial or incident infection
β
Just Accepted
π https://bit.ly/4jfAfv0
What happens when an antiviral works by causing mutations? In a new Letβs Talk ID episode, JID Deputy Editor Jonathan Li, MD, FIDSA talks the science behind molnupiravir and a recent paper that raised questions about its potential effects in mammalian cells.
Plasma Proteome Signature of Immune Inhibition is Associated with Cytomegalovirus in People with HIV-1
β
Just Accepted
https://bit.ly/3TNAras
Association of HPV16 E7-specific T cell responses in cervical lymphocytes and peripheral blood with regression of high-grade cervical intraepithelial neoplasia lesions
β
Just Accepted
π https://bit.ly/3Uhaosn
The host transcriptional response to real-world cryptococcosis in the setting of advanced HIV disease defines dysregulated immune responses that underlie increased vulnerability to infection
π Repost
π https://t.co/H4lU2m7TUS
On IDSAβs & HIVMAβs Science Speaks: Learn more about the efficacy of switching to doravirine/islatravir, how immunocompromised individuals hospitalized with COVID-19 remain at increased mortality risk and other research in @jidjournal.bsky.social to inform clinical practice. https://bit.ly/4AYYFzi
Risk maps and spatial models for clinical infectious disease decision-making
π Repost
π https://t.co/XYWXM7LUwL
Expert Consensus on Controlled Human Infection Studies for Gonorrhoea
π Repost
π https://t.co/JgmJ0w5CkC
Evaluation of Three Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccines RSV/ΞNS2/Ξ1313/I1314L, RSV/6120/ΞNS2/1030s, and RSV/276 in RSV Seronegative Children
β
Just Accepted
π https://bit.ly/4hHZDXA
Spatial Constraints Limit Natural Killer Cell Access to Germinal Center HIV Reservoirs in Lymph Nodes
π Repost
https://t.co/LswqrwxBJq
In Memoriam: Jacqueline Achkar, M.D., M.S. (1962 β 2026)
π Repost
π https://t.co/Fp3O1LxjnT
El NiΓ±o 2026β27 and DENV-3 in Latin America: A Narrowing Window for Preparedness
π Repost
π https://t.co/L95vT9wAdt
The host transcriptional response to real-world cryptococcosis in the setting of advanced HIV disease defines dysregulated immune responses that underlie increased vulnerability to infection
β
Just Accepted
π https://bit.ly/4yzUfgA
A novel decentralized rapid test for detection of HCV antigens using smart polymer technology: a prospective multinational study
π Repost
π https://t.co/K1WLaEmQ9S
MeropenemβColistin Combination Mitigates Porin-Associated Carbapenem Resistance Development in Ertapenem-Mono-Resistant Enterobacterales
π Repost
π https://t.co/1eQbLlRwnp
Population-level shift in ex vivo artemisinin susceptibility in Plasmodium falciparum: comparison of 2014β2015 and 2022β2024 surveys in northern Uganda
β
Just Accepted
π https://bit.ly/3VkH0Sk
Low birthweight and prematurity, but not malaria chemoprevention, are associated with reduced pneumococcal vaccine immunogenicity in Ugandan infants
β
Just Accepted
π https://bit.ly/4e6eCJU
Carbapenemase-producing Kluyvera spp.: epidemiology of an evolving species
β
Just Accepted
π https://bit.ly/4AIYjfZ